@viridiantherapeutics.com
Leveraging our core expertise in antibody discovery and engineering to develop optimized treatments for rare autoimmune conditions
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Viridian Therapeutics is a biopharmaceutical company dedicated to engineering medicines that improve patient care. They specialize in developing best-in-class therapeutic antibodies to address patients' most pressing needs. Their lead programs focus on monoclonal antibodies that harness groundbreaking clinical discoveries and proven technologies.
One of their programs, VRDN-001, is an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody being developed for the treatment of thyroid eye disease (TED). They also have VRDN-002 and VRDN-003, which are distinct IGF-1R monoclonal antibodies designed for subcutaneous injection to treat TED. Viridian Therapeutics takes a patient-centric approach, reimagining research and development in therapeutics.
They leverage proven biology and technology to efficiently craft impactful medicines that meet the needs of both patients and healthcare providers. Their innovative pipeline of candidate therapeutics reflects their commitment to improving patient outcomes. Stay updated with Viridian Therapeutics and their latest developments by visiting their website
Company Type
Public Company
Company Size
11-50
Year Founded
2007
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories